Researchers increase HIV treatment success rates by almost 18 percent

March 3, 2017 by Wendy Davidson

Researchers have been successful in increasing HIV treatment success rates by almost 18 percent.

Teams from the Universities of Aberdeen, Maastricht and the University and Academic Medical Centre in Amsterdam, developed a new programme designed to better assist treated for HIV in taking their medication prescribed to control the virus. 

The study, published today in The Lancet Infectious Diseases, reports that whilst HIV medication does not deliver a cure, it works so well that the life-expectancy of people living with HIV is quite similar to that of healthy people. Patients successfully treated for HIV are also extremely unlikely to transmit the virus to others. However, a significant proportion of people with HIV take their medication too irregularly for it to work well, or discontinue their medication entirely.

Irregular use of the medication – or 'non-adherence', means that the virus gets a chance to replicate again and can attack the immune system – potentially leading to AIDS.

Using a combination of self-management strategies, counselling and patients tracking their own medication use with electronic pill bottles, the study found an increase in treatment success rates of almost 18% compared to patients who received regular care.

Health Psychologists and clinicians from Aberdeen and the Netherlands carried out a trial of their intervention programme on more than two hundred patients over 15 months in 7 hospitals across the Netherlands. 

The amount of virus present in the blood, or viral load, was measured before and 3 times after the intervention. If patients had a detectable viral load at two consecutive time points after the intervention, it was labelled as 'treatment failure'.

Results showed a substantial reduction in treatment failure (over 60%) in those who received the intervention, compared to those who had received regular care.

The team also performed an economic evaluation on the intervention and found that as well as improving patients' quality-adjusted-life-years (the years people life in good health), it was also cost saving. If ten thousand patients would receive the intervention, it would save approximately 5 million Euro and lead to a gain of 340 quality-adjusted-life-years.

Professor Marijn de Bruin from the University of Aberdeen said: "This is the first adherence intervention in HIV care that demonstrates clinical and cost effectiveness. The intervention can be applied in routine clinical care, and the effects have been reproduced in consecutive trials''.

"Although today's HIV medications are very effective, they can have quite a few side-effects and people with HIV don't usually experience any symptoms of the disease, so – for these and other reasons - it is unsurprising that adherence among some patients is suboptimal.

"We designed a programme in such a way that it would fit in with routine care and only adds about 10 minutes to the consultation. 

"Our intervention has proved to be very successful at improving drug-adherence and in turn reducing treatment failure. Importantly, these effects were most profound amongst patient groups from which we know struggle most with this treatment.

"As well as important for patients' own health, having a very low means that people are extremely unlikely to transmit the virus to other people.  So not only is this a significant improvement to individual patients' health, it is also important for public health because it may help to curb the pandemic by interrupting the transmission of the virus.

"That the intervention also saved money – rather than required extra resources –was unexpected, and it strongly suggests that introducing this programme in routine HIV care is beneficial for patients and society.

"It is important to note that medication non-adherence is very common with long- and short-term treatments for many conditions, often contributing to poor patient outcomes and increased . We will therefore seek to adapt and test the benefits of this in a range of other chronic conditions."

Explore further: Many patients do not obtain medications when first prescribed

More information: Effectiveness and cost-effectiveness of a nurse-delivered intervention to improve adherence to treatment for HIV: a pragmatic, multicentre, open-label, randomised clinical trial. The Lancet. DOI: dx.doi.org/10.1016/S1473-3099(16)30534-5

Related Stories

Many patients do not obtain medications when first prescribed

February 23, 2017
A new analysis indicates that not obtaining a medication the first time it is prescribed—called initial medication non-adherence—is common among patients within the Catalan health system in Spain.

Adults who struggle to follow heart medication regimens should focus on behavior change

April 1, 2015
Unlike some conditions, heart failure must be managed by patients taking prescriptions for the rest of their lives. Individuals who do not take their heart medication as prescribed have increased risks of mortality and hospitalization ...

Medication adherence after hospitalization for acute coronary syndrome

November 18, 2013
Patients better adhered to their medication regimens in the year following hospitalization for acute coronary syndrome (ACS) when they were part of a program that included personalized attention from a pharmacist compared ...

Telephone intervention doesn't aid diabetes meds adherence

October 27, 2014
(HealthDay)—Telephone outreach does not improve medication adherence or metabolic control in adults with diabetes, according to a study published online Oct. 14 in Diabetes Care.

Mobile health interventions no silver bullet for diabetes patients, says study

November 8, 2016
Globally about 442 million people live with diabetes, most of them in low-income countries, where health systems often function poorly. As they are not equipped to follow-up on patients or improve the quality of care, chronic ...

New study to help people withdraw from inappropriate long-term antidepressant treatment

July 25, 2016
One in 10 adults are being given antidepressants each year, but up to 50 per cent of patients could be given an alternative treatment, a University Professor suggests.

Recommended for you

Researchers create molecule that could 'kick and kill' HIV

October 5, 2017
Current anti-AIDS drugs are highly effective at making HIV undetectable and allowing people with the virus to live longer, healthier lives. The treatments, a class of medications called antiretroviral therapy, also greatly ...

A sixth of new HIV patients in Europe 50 or older: study

September 27, 2017
People aged 50 and older comprise a growing percentage of HIV patients in Europe, accounting for one in six new cases in 2015, researchers said Wednesday.

Three-in-one antibody protects monkeys from HIV-like virus

September 20, 2017
A three-pronged antibody made in the laboratory protected monkeys from infection with two strains of SHIV, a monkey form of HIV, better than individual natural antibodies from which the engineered antibody is derived, researchers ...

Fighting HIV on multiple fronts might lead to vaccine

September 20, 2017
A combination antibody strategy could be the key to halting the spread of HIV, according to results from two promising animal studies.

HIV-AIDS: Following your gut

September 18, 2017
Researchers at the University of Montreal Hospital Research Centre (CRCHUM) have discovered a way to slow viral replication in the gastrointestinal tract of people infected by HIV-AIDS.

Study finds cutbacks in foreign aid for HIV treatment would cause great harm

August 30, 2017
Proposed reductions in U.S. foreign aid would have a devastating impact on HIV treatment and prevention programs in countries receiving such aid, an international team of investigators reports. In their paper published online ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.